EDGEWISE THERAPEUTICS INC (EWTX)
US28036F1057 - Common Stock
ChartMill assigns a Buy % Consensus number of 85% to EWTX. The Buy consensus is the weighted average rating of the current analysts ratings.
Analysts have set a mean price target forecast of 31.11. This target is 95.17% above the current price.
EWTX was analyzed by 12 analysts. The buy percentage consensus is at 85. So analysts seem to be very confident about EWTX.
In the previous month the buy percentage consensus was at a similar level.
EWTX was analyzed by 12 analysts, which is quite many. So the average rating should be quite meaningful.
Price Target & Forecast
| Date | Firm | Action | Rating |
|---|---|---|---|
| 2024-04-22 | RBC Capital | Maintains | Outperform -> Outperform |
| 2024-04-17 | Truist Securities | Maintains | Buy -> Buy |
| 2024-04-16 | Wedbush | Reiterate | Outperform -> Outperform |
| 2024-03-12 | RBC Capital | Reiterate | Outperform -> Outperform |
| 2024-03-07 | Piper Sandler | Initiate | Overweight |
| 2023-11-10 | Wedbush | Maintains | Outperform -> Outperform |
| 2023-08-16 | Wedbush | Reiterate | Outperform -> Outperform |
| 2023-08-11 | Wedbush | Reiterate | Outperform -> Outperform |
| 2023-06-30 | JP Morgan | Maintains | Overweight -> Overweight |
| 2023-06-28 | RBC Capital | Reiterate | Outperform -> Outperform |
| 2023-06-28 | Truist Securities | Reiterate | Buy -> Buy |
| 2023-06-27 | Truist Securities | Reiterate | Buy -> Buy |
| 2023-05-16 | JP Morgan | Maintains | Overweight -> Overweight |
| 2023-05-12 | Wedbush | Reiterate | Outperform -> Outperform |
| 2023-05-01 | Truist Securities | Initiate | Buy |
| 2022-11-04 | RBC Capital | Maintains | Outperform |
| 2022-08-25 | Goldman Sachs | Downgrade | Neutral -> Sell |
| 2022-05-24 | Goldman Sachs | Maintains | Neutral |
| 2022-05-12 | SVB Leerink | Maintains | Outperform |
| 2022-05-12 | Goldman Sachs | Maintains | Neutral |
| 2022-04-13 | RBC Capital | Initiate | Outperform |
| 2022-02-14 | JP Morgan | Maintains | Overweight |
| 2022-01-06 | JP Morgan | Maintains | Overweight |
| 2021-04-20 | SVB Leerink | Initiate | Outperform |
| 2021-04-20 | Wedbush | Initiate | Outperform |
| 2021-04-20 | JP Morgan | Initiate | Overweight |
| 2021-04-19 | Goldman Sachs | Initiate | Neutral |